글로벌 황반변성 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 황반변성 치료 시장

황반변성 치료 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 시장이 6.80%의 CAGR로 성장하고 2028년까지 13108.05백만 달러에 도달할 것으로 예상하여 분석합니다.

황반변성은 눈 의 황반부에 영향을 미치는 신경퇴행성 안구 질환입니다 . 황반변성은 물체를 선명하게 보는 데 필요한 선명하고 중앙의 시력을 제공하기 때문에 중앙 시력을 잃게 됩니다. 황반변성은 중심와 주변의 모세혈관이 확장되어 누출될 때 발생합니다. 이로 인해 빛의 반사를 방해하고 점진적인 시력 상실을 유발하는 체액이 축적됩니다. 주로 50~60세의 사람들에게 영향을 미칩니다. 이 질환은 야맹증, 터널 비전 및 중앙 시력 상실이 특징입니다. 연령 관련 황반변성(AMD)이라고도 합니다. 

신경영양성 각막염에 기여할 수 있기 때문에 안구 표면 손상의 발생률이 증가하고, 진보된 치료법이 개발되는 것이 시장 성장에 영향을 미치는 주요 요인입니다. 게다가, 새로운 개입의 개발을 위한 연구자에 대한 막대한 재정 지원, 규제 당국에 대한 특별 지정 증가, 시력을 개선할 수 있는 세포 치료법 의 발전 은 황반변성 치료 시장을 확대할 요인입니다.

새로운 치료법에 대한 수요 증가와 연구 개발 활동에 대한 막대한 투자는 2021~2028년 예측 기간 동안 황반변성 치료 시장에 유익한 기회를 제공할 것입니다.

그러나 개발도상국의 낮은 의료 예산과 치료와 관련된 높은 비용은 시장 성장을 방해하는 요인입니다. 수술적 치료는 눈의 모양과 기능을 변화시킬 수 있으며, 위에서 언급한 예측 기간 동안 황반변성 치료 시장에 도전할 것입니다.

This Macular degeneration treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Macular degeneration treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Macular Degeneration Treatment Market Scope and Market Size

The Macular degeneration treatment market is segmented on the basis of type, treatment, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the Macular degeneration treatment market is segmented into wet macular degeneration and dry macular degeneration.
• On the basis of treatment, the Macular degeneration treatment market is segmented into drugs and surgery. Drugs have been further sub-segmented into ranibizumab, aflibercept and others. Surgery has been further sub-segmented into laser photocoagulation surgery and subretinal surgery.
• On the basis of route of administration, the Macular degeneration treatment market is segmented into oral, injectable and others.
• On the basis of end-users, the Macular degeneration treatment market is segmented into hospitals, homecare, specialty clinics, ophthalmic clinic and others.
• The Macular degeneration treatment market is also segmented on the basis of distribution channel into hospital pharmacies, retail pharmacies and online pharmacies.

Macular Degeneration Treatment Market Country Level Analysis

Macular degeneration treatment market is analyzed and market size information is provided by the country, type, treatment, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Macular degeneration treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the Macular degeneration treatment market due to the presence of major key players, rise in the prevalence of eye disorders, increasing geriatric population, favourable reimbursement policies and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the rise in the prevalence macular degeneration, surge in the investment for healthcare sector, growing awareness and increase in the disposable income.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Macular degeneration treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Macular Degeneration Treatment Market Share Analysis

Macular degeneration treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to macular degeneration treatment market research.

황반변성 치료 시장 보고서에서 다루는 주요 기업으로는 Adverum Biotechnologies Inc., Neurotech, Gilead Sciences, Inc., F. Hoffmann-La Roche Ltd, Allergan, Regeneron Pharmaceuticals, Inc, STEMCELL Technologies Inc, IVERIC bio, Inc., SANWA KAGAKU KENKYUSHO CO.,LTD., Bausch Health Companies Inc., Alcon Vision LLC, Phio Therapeutics Corp., Kubota Pharmaceutical Holdings Co., Ltd, Bayer AG, Novartis AG, Opthea, Santen Pharmaceutical Co., Ltd, PanOptica, Inc, Resolvyx Pharmaceuticals, Inc 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-47883